logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (vii) Percentage distribution of all inpatient clients by age group for each primary drug

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge knownAge not known
Hypnotics and sedatives0.24.27.713.
Volatile substances5.334.725.616.77.54.823.323.854414
Other substances 1.610.221.618.513.711.18.714.631.2244631


 The countries supplying data are: 

 BG, CZ, DK, DE, IE, GR, CY, LU, HU, AT, RO, SK, FI, SE, UK, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-105 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008